Pure Global

ATB STREP CLSI (12) - Taiwan Registration aa3efb7211008278fe2772d638c63a58

Access comprehensive regulatory information for ATB STREP CLSI (12) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number aa3efb7211008278fe2772d638c63a58 and manufactured by bioMรฉrieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mรฉrieux S.p.A. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
aa3efb7211008278fe2772d638c63a58
Registration Details
Taiwan FDA Registration: aa3efb7211008278fe2772d638c63a58
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

ATB STREP CLSI (12)
TW: ๅ„ชๅฟ…้ˆ็ƒ่Œ่—ฅ็‰ฉๆ•ๆ„Ÿๆ€ง่ฉฆ้ฉ—ๅฅ—็ต„
Risk Class 2
MD

Registration Details

aa3efb7211008278fe2772d638c63a58

Ministry of Health Medical Device Import No. 030473

DHA05603047301

Company Information

Product Details

This product is used for streptococcal and pneumococcal drug susceptibility test.

C Immunology and microbiology devices

C1640 Antimicrobial susceptibility test powder

Imported from abroad

Dates and Status

Dec 21, 2017

Dec 21, 2022